1-11 of 11
Mathew Simcock
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy, Safety, and Pharmacokinetics (PK) of Azacitidine (AZA) in Children and Young Adults with Acute Myeloid Leukemia (AML) in the Phase 2 AZA-AML-004 Trial

Dirk Reinhardt, MD, Henrik Hasle, PhD, Karsten Nysom, André Baruchel, Franco Locatelli, MD PhD, Bouchra Benettaib, Noha Biserna, Meera Patturajan, Mathew Simcock, Allison Gaudy, C. Michel Zwaan
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-137043
Published: 2020
Journal Articles

Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myeloma

Clinical Trials & Observations
Meletios A. Dimopoulos, Antonio Palumbo, Paolo Corradini, Michele Cavo, Michel Delforge, Francesco Di Raimondo, Katja C. Weisel, Albert Oriol, Markus Hansson, Angelo Vacca, María Jesús Blanchard, Hartmut Goldschmidt, Chantal Doyen, Martin Kaiser, Mario Petrini, Pekka Anttila, Anna Maria Cafro, Reinier Raymakers, Jesus San-Miguel, Felipe de Arriba, Stefan Knop, Christoph Röllig, Enrique M. Ocio, Gareth Morgan, Neil Miller, Mathew Simcock, Teresa Peluso, Jennifer Herring, Lars Sternas, Mohamed H. Zaki, Philippe Moreau
Journal: Blood
Blood (2016) 128 (4): 497–503.
https://doi.org/10.1182/blood-2016-02-700872
Published: 2016
Journal Articles

An Updated Analysis of the Stratus Trial (MM-010): Safety and Efficacy of Pomalidomide Plus Low-Dose Dexamethasone (POM + LoDEX) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

Meletios A. Dimopoulos, Antonio Palumbo, Paolo Corradini, Michele Cavo, Michel Delforge, Katja C. Weisel, Enrique M. Ocio, MD PhD, Francesco Di Raimondo, Markus Hansson, Mathew Simcock, Neil Miller, Ana Slaughter, Teresa Peluso, Lars Sternas, Mohamed H Zaki, Philippe Moreau
Journal: Blood
Blood (2015) 126 (23): 4225.
https://doi.org/10.1182/blood.V126.23.4225.4225
Published: 2015
Journal Articles

Analysis of Patient (Pt) Outcomes By Prior Treatment and Depth of Response in Stratus (MM-010), a Phase 3b Study of Pomalidomide + Low-Dose Dexamethasone (POM + LoDEX) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

Philippe Moreau, Antonio Palumbo, Paolo Corradini, Michele Cavo, Michel Delforge, Katja C. Weisel, Enrique M. Ocio, MD PhD, Annamaria Cafro, Christoph Rollig, Stefan Knop, Felipe de Arriba, Mathew Simcock, Neil Miller, Ana Slaughter, Latisha Watkins, Jennifer Herring, Tsvetan Biyukov, Teresa Peluso, Mohamed H Zaki, Meletios A. Dimopoulos
Journal: Blood
Blood (2015) 126 (23): 1834.
https://doi.org/10.1182/blood.V126.23.1834.1834
Published: 2015
Journal Articles

Safety and Efficacy of Pomalidomide Plus Low-Dose Dexamethasone (POM + LoDEX) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM) in Italy: A Subanalysis of the Stratus Trial (MM-010)

Michele Cavo, Paolo Corradini, Francesco Di Raimondo, Mario Petrini, Anna Maria Cafro, Tommaso Caravita di Toritto, Massimo Offidani, Gianpietro Semenzato, Renato Zambello, Antonio Lazzaro, Maria Teresa Petrucci, Francesco Rodeghiero, Mathew Simcock, Ana Slaughter, Jennifer Herring, Teresa Peluso, Antonio Palumbo
Journal: Blood
Blood (2015) 126 (23): 5376.
https://doi.org/10.1182/blood.V126.23.5376.5376
Published: 2015
Journal Articles

Safety and Efficacy in the Stratus (MM-010) Trial, a Single-Arm Phase 3b Study Evaluating Pomalidomide + Low-Dose Dexamethasone in Patients with Refractory or Relapsed and Refractory Multiple Myeloma

Meletios A. Dimopoulos, MD, Antonio Palumbo, MD, Katja Weisel, MD, Enrique M. Ocio, MD PhD, Michele Cavo, MD, Paolo Corradini, MD PhD, Michel Delforge, MD PhF, Albert Oriol, MD, Hartmut Goldschmidt, MD, María Jesús Blanchard, MD, Chantal Doyen, MD, Gareth J Morgan, MD PhD, Mathew Simcock, MSc, Neil Miller, CRS, Ana Slaughter, PhD, Teresa Peluso, MBBS, Lars Sternas, MD, Mohamed H. Zaki, MD PhD, Philippe Moreau, MD
Journal: Blood
Blood (2014) 124 (21): 80.
https://doi.org/10.1182/blood.V124.21.80.80
Published: 2014
Journal Articles

Outcomes for Older Patients in Stratus (MM-010), a Single-Arm, and Phase 3b Study of Pomalidomide + Low-Dose Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma

Antonio Palumbo, MD, Meletios A. Dimopoulos, MD, Katja Weisel, MD, Michele Cavo, MD, Enrique M. Ocio, MD PhD, Paolo Corradini, MD PhD, Michel Delforge, MD PhF, Albert Oriol, MD, Hartmut Goldschmidt, MD, Maria Jesus Blanchard, MD, Concetta Conticello, MD, Angelo Vacca, MD PhD, Markus Hansson, MD PhD, Ana Slaughter, PhD, Mathew Simcock, MSc, Jennifer Herring, MD, Teresa Peluso, MBBS, Lars Sternas, MD, Mohamed H. Zaki, MD PhD, Philippe Moreau
Journal: Blood
Blood (2014) 124 (21): 4770.
https://doi.org/10.1182/blood.V124.21.4770.4770
Published: 2014
Journal Articles

Experience with Long-Term Lenalidomide (LEN) Treatment in the Clinical Setting: Results From the UK Revlimid ® Treatment Continuation Scheme™ (TCS)

Cathy D. Williams, MBBS, MCRP, FRCPath, Mathew Simcock, MSc, Imran Lodhi, MBBS, Suzanne K. Robinson, PhD, Faith E. Davies, MD
Journal: Blood
Blood (2012) 120 (21): 4067.
https://doi.org/10.1182/blood.V120.21.4067.4067
Published: 2012
Journal Articles

Rituximab Maintenance Treatment for a Maximum of 5 Years In Follicular Lymphoma: Safety Analysis of the Randomized Phase III Trial SAKK 35/03

Christian J. Taverna, MD, Simona Bassi, Felicitas Hitz, Walter Mingrone, Thomas Pabst, Lidija Cevreska, MD, PhD, Auro del Giglio, MD, Daniel A. Vorobiof, Mathew Simcock, Michele Ghielmini, MD
Journal: Blood
Blood (2010) 116 (21): 1802.
https://doi.org/10.1182/blood.V116.21.1802.1802
Published: 2010
Journal Articles

Immunosuppression for Patients with Low and Intermediate Risk Myelodysplastic Syndrome: A Prospective Randomized Multicenter Trial Comparing Antithymocyte Globulin + Cyclosporine with Best Supportive Care: SAKK 33/99.

Jakob R. Passweg, Aristoteles Giagounidis, Mathew Simcock, Carlo Aul, Christiane Dobbelstein, Michael Stadler, Gert Ossenkoppele, Wolf K. Hofmann, Andre Tichelli, Arnold Ganser
Journal: Blood
Blood (2007) 110 (11): 1461.
https://doi.org/10.1182/blood.V110.11.1461.1461
Published: 2007
Journal Articles

A Multicentre Phase II Trial Testing Gemcitabine in the Treatment of Patients with Newly Diagnosed, Relapsed or Chemotherapy Resistant Mantle Cell Lymphoma: SAKK 36/03.

Felicitas Hitz, MD, Giovanni Martinelli, MD, Emanuele Zucca, MD, Walter Mingrone, MD, Roger Von Moos, MD, Mathew Simcock, Jenny Peterson, Sergio Cogliatti, MD, Francesco Bertoni, MD, Michele Ghielmini, MD
Journal: Blood
Blood (2007) 110 (11): 4454.
https://doi.org/10.1182/blood.V110.11.4454.4454
Published: 2007